Aigars Jirgensons

1.5k total citations
109 papers, 1.1k citations indexed

About

Aigars Jirgensons is a scholar working on Organic Chemistry, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Aigars Jirgensons has authored 109 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Organic Chemistry, 53 papers in Molecular Biology and 16 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Aigars Jirgensons's work include Asymmetric Synthesis and Catalysis (21 papers), Chemical Synthesis and Analysis (19 papers) and Synthetic Organic Chemistry Methods (19 papers). Aigars Jirgensons is often cited by papers focused on Asymmetric Synthesis and Catalysis (21 papers), Chemical Synthesis and Analysis (19 papers) and Synthetic Organic Chemistry Methods (19 papers). Aigars Jirgensons collaborates with scholars based in Latvia, Russia and United Kingdom. Aigars Jirgensons's co-authors include Liene Grigorjeva, Kristaps Jaudzems, Dace Rasiņa, Ivars Kalvinsh, Michael J. Blackman, I. Kanepe, Raitis Bobrovs, Kaspars Tārs, Chrislaine Withers‐Martinez and Paul W. Finn and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Molecular Biology and Journal of Medicinal Chemistry.

In The Last Decade

Aigars Jirgensons

103 papers receiving 1.1k citations

Peers

Aigars Jirgensons
Siegfried S. F. Leung United States
Salvatore Ferla United Kingdom
Tasir S. Haque United States
Wilian A. Cortopassi United States
Kirsten S. Smith United States
Marcella Bassetto United Kingdom
Roman Manetsch United States
Michael C. Myers United States
Siegfried S. F. Leung United States
Aigars Jirgensons
Citations per year, relative to Aigars Jirgensons Aigars Jirgensons (= 1×) peers Siegfried S. F. Leung

Countries citing papers authored by Aigars Jirgensons

Since Specialization
Citations

This map shows the geographic impact of Aigars Jirgensons's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aigars Jirgensons with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aigars Jirgensons more than expected).

Fields of papers citing papers by Aigars Jirgensons

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aigars Jirgensons. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aigars Jirgensons. The network helps show where Aigars Jirgensons may publish in the future.

Co-authorship network of co-authors of Aigars Jirgensons

This figure shows the co-authorship network connecting the top 25 collaborators of Aigars Jirgensons. A scholar is included among the top collaborators of Aigars Jirgensons based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aigars Jirgensons. Aigars Jirgensons is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Withers‐Martinez, Chrislaine, Roger George, R.W. Ogrodowicz, et al.. (2025). Structural Plasticity of Plasmodium falciparum Plasmepsin X to Accommodate Binding of Potent Macrocyclic Hydroxyethylamine Inhibitors. Journal of Molecular Biology. 437(10). 169062–169062.
2.
Velikova, Nadya, et al.. (2024). Repurposing Hsp90 inhibitors as antimicrobials targeting two-component systems identifies compounds leading to loss of bacterial membrane integrity. Microbiology Spectrum. 12(8). e0014624–e0014624. 2 indexed citations
3.
Kalnins, G., et al.. (2024). Structural Basis for Inhibition of the SARS‐CoV‐2 nsp16 by Substrate‐Based Dual Site Inhibitors. ChemMedChem. 19(24). e202400618–e202400618.
4.
Bobrovs, Raitis, Žilvinas Dambrauskas, Antanas Gulbinas, et al.. (2024). Discovery and optimisation of pyrazolo[1,5-a]pyrimidines as aryl hydrocarbon receptor antagonists. RSC Medicinal Chemistry. 15(10). 3477–3484. 2 indexed citations
5.
Jirgensons, Aigars, et al.. (2024). Synthesis of 2-arylquinazolines by Chan–Evans–Lam coupling of 2-formylphenylboronic acids with amidines. Chemistry of Heterocyclic Compounds. 60(3-4). 169–174. 1 indexed citations
6.
Rasiņa, Dace, et al.. (2024). Bridgehead epoxide iso-euphoranin E from β-caryophyllene oxide via sequential cationic formation and scission of [4.3.2]propellane. Organic Chemistry Frontiers. 11(18). 5086–5092. 1 indexed citations
7.
Sreeramulu, Sridhar, Christian Richter, Edgar Specker, et al.. (2024). Design, quality and validation of the EU-OPENSCREEN fragment library poised to a high-throughput screening collection. RSC Medicinal Chemistry. 15(4). 1176–1188. 7 indexed citations
8.
Velikova, Nadya, et al.. (2022). Synthesis and SAR of phenylazoles, active against Staphylococcus aureus Newman. Chemistry of Heterocyclic Compounds. 58(12). 737–748. 4 indexed citations
9.
Withers‐Martinez, Chrislaine, Fiona Hackett, Christine R. Collins, et al.. (2021). Peptidic boronic acids are potent cell-permeable inhibitors of the malaria parasite egress serine protease SUB1. Proceedings of the National Academy of Sciences. 118(20). 17 indexed citations
10.
Bobrovs, Raitis, et al.. (2018). Azole‐based non‐peptidomimetic plasmepsin inhibitors. Archiv der Pharmazie. 351(9). e1800151–e1800151. 7 indexed citations
11.
Rasiņa, Dace, et al.. (2018). 2-Aminoquinazolin-4(3H)-One Based Plasmepsin Inhibitors with Improved Hydrophilicity and Selectivity. publication.editionName. 2488–2500. 1 indexed citations
12.
Withers‐Martinez, Chrislaine, Michael J. Blackman, Raitis Bobrovs, et al.. (2018). Peptidomimetic plasmepsin inhibitors with potent anti-malarial activity and selectivity against cathepsin D. European Journal of Medicinal Chemistry. 163. 344–352. 20 indexed citations
13.
Rasiņa, Dace, Raitis Bobrovs, I. Kanepe, et al.. (2018). 2-Aminoquinazolin-4(3H)-one based plasmepsin inhibitors with improved hydrophilicity and selectivity. Bioorganic & Medicinal Chemistry. 26(9). 2488–2500. 9 indexed citations
14.
Gupta, Ashwani, Dace Rasiņa, Christopher P. Randall, et al.. (2016). A Polymorphism in leuS Confers Reduced Susceptibility to GSK2251052 in a Clinical Isolate of Staphylococcus Aureus. publication.editionName. 60. 3219–3221. 1 indexed citations
15.
Shestakova, Irīna, et al.. (2015). Synthesis and Biological Evaluation of Aziridin-1-Yl Oxime-Based Vorinostat Analogs as Anticancer Agents. publication.editionName. 647–657.
16.
Penzo, Maria, et al.. (2014). Substrate derived peptidic α-ketoamides as inhibitors of the malarial protease PfSUB1. Bioorganic & Medicinal Chemistry Letters. 24(18). 4486–4489. 28 indexed citations
17.
Jirgensons, Aigars, et al.. (2013). SYNTHESIS, CHEMICAL AND BIOLOGICAL PROPERTIES OF AZIRIDINE-1-CARBALDEHYDE OXIMES. Chemistry of Heterocyclic Compounds. 1669–1684. 2 indexed citations
18.
Kļimoviča, Kristīne, Liene Grigorjeva, Ansis Maļeckis, J. Popelis, & Aigars Jirgensons. (2012). C-Quaternary Vinylglycinols by Metal-Catalyzed Cyclization of Allylic Bistrichloroacetimidates. publication.editionName. 198–198. 1 indexed citations
19.
Jirgensons, Aigars, et al.. (2012). Synthesis of Hydroxamic Acids by Using the Acid Labile O-2-Methylprenyl Protecting Group. publication.editionName. 23. 2972–2974.
20.
Kļimoviča, Kristīne, Liene Grigorjeva, Ansis Maļeckis, J. Popelis, & Aigars Jirgensons. (2011). C-Quaternary Vinylglycinols by Metal-Catalyzed Cyclization of Allylic. publication.editionName. 2849–2851. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026